BIP! Finder - The impact of rituximab infusion protocol on the long-term outcome in anti-MuSK myasthenia gravis.

Clear all

2018 • The impact of rituximab infusion protocol on the long-term outcome in anti-MuSK myasthenia gravis.

Authors: Cortés-Vicente, Elena, Rojas-Garcia, Ricard, Diaz-Manera, Jordi, Querol, Luis, Casasnovas, Carlos, Guerrero-Sola, Antonio, Muñoz-Blanco, José Luis, Bárcena-Llona, José Eulalio, Márquez-Infante, Celedonio, Pardo, Julio, Martínez-Fernández, Eva (...) (Read More)

Abstract: I. Illa received research support from the Fondo de Investigacion en Salud, Instituto de Salud Carlos III, Ministry of Health (Spain), FIS PI16/01440 (Fondos FEDER). E. Cortes-Vicente was supported by a FIS grant (CM16/00096) from Fondo de Investigacion en Salud, Instituto de Salud Carlos III, Ministry of Health (Spain) and Fondo Social Europeo.

External links: OpenAIRE

Works in BIP! associated with the specified OpenAIRE research product

The impact of rituximab infusion protocol on the long-term outcome in anti-MuSK myasthenia (...)

Cortés-Vicente, Elena, Rojas-Garcia, Ricard, Diaz-Manera, Jordi, Querol, Luis, Casasnovas, Carlos, (...)

Annals of Clinical and Translational Neurology · 2018

Internal medicine | Surgery |

Open Access

Publication